Does Nilutamide Interact with Phenytoin?
CDI records a major classification for Nilutamide and Phenytoin. The stored summary is: Nilutamide inhibits cytochrome P-450 isoenzymes, reducing metabolism of phenytoin and increasing serum half-life, potentially leading to toxic levels. Dosage may need modification. The mechanism involves inhibition of hepatic cytochrome p-450 isoenzymes reducing drug metabolism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Nilutamide Class
- Androgen Receptor Inhibitor
- Phenytoin Class
- Anti-epileptic Agent
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Inhibition of hepatic cytochrome P-450 isoenzymes reducing drug metabolism
What To Tell Your Doctor or Pharmacist
If you are taking Nilutamide and your doctor is considering prescribing Phenytoin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider